10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antiparasitic Drugs play a crucial role in combating various parasitic infections, contributing significantly to the broader category of antimicrobials. These drugs target parasites that cause diseases in humans, animals, and plants. The diverse nature of parasitic organisms requires a range of antiparasitic drugs to effectively manage infections. One class of antiparasitic drugs includes antimalarials, such as chloroquine and artemisinin derivatives, which specifically target malaria parasites. These drugs disrupt the life cycle of the parasite within the human host, preventing the spread and severity of the disease. Another important group is the anthelmintics, which combat worm infections. Drugs like albendazole and mebendazole are commonly used to treat intestinal helminth infections, offering relief from conditions like roundworm and hookworm infestations. Additionally, antiprotozoal drugs, like metronidazole and atovaquone, are essential in managing infections caused by protozoa. These drugs interfere with the metabolic processes of the protozoan parasites, impeding their ability to survive and reproduce within the host organism.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria